GE HealthCare preliminary Q4 revenue ~$4.9B (+7% YoY); 2023 organic growth guidance 5-7%

GE HealthCare Technologies Inc.

2023-FY EPS reported $4.22 revenue$18,341,000,000

Q4 2022 revenue ~$4.9B, up ~7% YoY; organic revenue growth ~12% YoY.
Full-year 2022 revenue ~$18.3B, up ~4% YoY; organic revenue growth ~7% YoY.
Full-year 2022 adjusted EBIT above outlook; free cash flow toward low end of guidance.
2023 outlook: organic revenue growth 5-7%; adjusted EBIT margin 15.0-15.5% (up 50-100 bps).
2023 free cash flow conversion guidance of 85%+.

item 2.02 item 7.01 item 8.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

GE HealthCare Technologies Inc. reported fourth quarter and fiscal year ended December 31, 2022 results: revenue approximately $4.9 billion. Guidance initiated.

Period: fourth quarter and fiscal year ended December 31, 2022
Revenue: approximately $4.9 billion
Guidance: initiated
Result: preliminary results

Exact text from the filing

solve some of the most significant clinical challenges with our precision care strategy.” Preliminary Fourth Quarter 2022 Results Fourth quarter 2022 revenue was approximately $4.9 billion. Revenue growth for the quarter was approximately 7% year over year. Organic revenue growth* for the quarter was approximately 12% year over year. Unless stated otherwise, all

View on SEC.gov

Browse all earnings releases →

GE HealthCare Technologies Inc. filing history →

Source: SEC EDGAR

accession 0001932393-23-000004

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.